Somerset, United Kingdom

Benjamin Greedy

USPTO Granted Patents = 4 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2011-2020

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Benjamin Greedy in Cancer Research

Introduction

Benjamin Greedy is an accomplished inventor based in Somerset, GB. He has made significant contributions to the field of cancer research, particularly through his innovative work on small molecule inhibitors of STAT3. With a total of 4 patents, Greedy's inventions focus on developing compounds that can potentially treat various forms of cancer and other diseases characterized by cell proliferation.

Latest Patents

Greedy's latest patents revolve around small molecule inhibitors of STAT3 with anti-tumor activity. These inventions concern compounds and compositions that inhibit Stat3 signaling, Stat3 dimerization, and Stat3-DNA binding. The compounds include, but are not limited to, NSC 74859 (S3I-201), NSC 42067, NSC 59263, NSC 75912, NSC 11421, NSC 91529, and NSC 263435. These compounds are designed to be used as anti-cancer agents for the treatment of various cancers, including breast cancer. Additionally, the inventions address other non-malignant diseases characterized by cell proliferation, such as cirrhosis of the liver and autoimmune diseases like type 1 diabetes and lupus. The patents also include methods for screening malignant cells and identifying inhibitors of Stat3 activation.

Career Highlights

Throughout his career, Benjamin Greedy has worked with notable institutions, including the University of South Florida and the University of Central Florida Research Foundation, Inc. His research has significantly advanced the understanding of cancer treatment and the development of therapeutic agents.

Collaborations

Greedy has collaborated with esteemed colleagues such as James Turkson and Said M Sebti. These partnerships have further enriched his research and contributed to the success of his inventions.

Conclusion

Benjamin Greedy's innovative work in developing small molecule inhibitors of STAT3 showcases his commitment to advancing cancer research. His contributions have the potential to impact the treatment of various cancers and other diseases characterized by cell proliferation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…